Jenna joined SV Health Investors in 2026 and is a Vice President in the DDF team.
Prior to joining SV, Jenna was a Principal at Two Bear Capital, where she sourced, diligenced, and led investments in innovative life sciences therapeutics companies and served as board observer for Montara Therapeutics and Abilita Therapeutics. She previously worked as a researcher at the MassGeneral Institute for Neurodegenerative Disease (Massachusetts General Hospital/Harvard Medical School), developing 3D human neural stem cell models of Alzheimer’s disease with Dr. Rudy Tanzi. She also served as an external business advisor to The Michael J. Fox Foundation.
Jenna received a PhD in Brain & Cognitive Sciences from MIT, where she developed biotechnology platforms for higher-resolution analysis of clinical samples, including brain tissue and liquid biopsies, with applications in neurodegeneration and cancer. Her doctoral training was supported by fellowships from the Singleton Foundation and the Center for Neurobiological Engineering, as well as a Koch Frontiers Award.
Outside of SV, Jenna enjoys skiing, sailing, and playing the cello.
Academic Credentials
PhD in Brain & Cognitive Sciences from MIT
BS in Biology (Honors, Cum Laude) from the University of Massachusetts Boston
